Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor

• Autorzy: Funa K. , Uramoto H.
• Języki publikacji: EN

Abstrakty

EN

PDGF is one of the most potent serum mitogens, and the signalling mechanism by way of its receptor tyrosine-kinase has been extensively studied since its first purifica­tion in 1979. The identification of homology between the simian sarcoma virus onco­gene, v-sis, and the B-chain of PDGF, as well as the frequent over-expression of both the ligands and receptors in various tumours and stroma led to the proposal of the PDGF-mediated autocrine and paracrine hypothesis. Consistent with the important roles of PDGF in the growth and survival of cells, the expression and activity of PDGF receptors are tightly controlled by both positive and negative feedback mechanisms at different levels. The deregulation of the control system can result in serious pathological conditions such as chronic inflammation and tumours. Understanding the molecular mechanisms for the regulatory system and the signalling pathway of PDGF is essential in order to find effective therapies in the diseases where PDGF is involved.

Słowa kluczowe

EN

receptor; platelet-derived growth factor; purification; signalling mechanism; tyrosine kinase; expression; growth factor

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2003
• Tom: 50
• Numer: 3
• Opis fizyczny: p.647-658

Twórcy

autor

Funa K.

• Goteborg University, Box 420, SE-405 30 Gothenburg, Sweden

autor

Uramoto H.

Bibliografia

• Afink GB, Nister M, Stassen BH, Joosten PH, Rademakers PJ, Bongcam-Rudloff E, Van Zoelen EJ, Mosselman S. (1995) Molecular cloning and functional characterization of the human platelet-derived growth factor alpha receptor gene promoter. Oncogene.; 10: 1667-72.
• Andrae J, Molander C, Smits A, Funa K, Nister M. (2002) Platelet-derived growth factor-B and -C and active alpha- receptors in medulloblastoma cells. Biochem Biophys Res Commun.; 296: 604-11.
• Ballagi AE, Ishizaki A, Nehlin JO, Funa K. (1995) Isolation and characterization of the mouse PDGF beta-receptor promoter. Biochem Biophys Res Commun.; 210: 165-73.
• Barone MV, Courtneidge SA. (1995) Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature.; 378: 509-12.
• Barrett TB, Seifert RA, Bowen-Pope DF. (1996) Regulation of platelet-derived growth factor receptor expression by cell context overrides regulation by cytokines. J Cell Physiol.; 169: 126-38.
• Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. (1990) TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell.; 63: 515-24.
• Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest.; 111: 1287-95.
• Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U. (2001) PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol.; 3: 512-6.
• Bonner JC, Badgett A, Lindroos PM, Coin PG. (1996) Basic fibroblast growth factor induces expression of the PDGF receptor-alpha on human bronchial smooth muscle cells. Am J Physiol.; 271: L880-8.
• Chiarugi P, Cirri P, Marra F, Raugei G, Fiaschi T, Camici G, Manao G, Romanelli RG, Ramponi G. (1998) The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine- protein phosphatase in platelet-derived growth factor signaling. J Biol Chem.; 273: 6776-85.
• Chiarugi P, Cirri P, Taddei ML, Talini D, Doria L, Fiaschi T, Buricchi F, Giannoni E, Camici G, Raugei G, Ramponi G. (2002) New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases. J Cell Sci.; 115: 2219-32.
• Cook JR, Wang DY, Chen JK. (1993) Nonresponsiveness of an SV40-transformed Balb/c-3T3 cell line to PDGF mitogenicity is correlated with an irreversible reduction in PDGF receptor number. Life Sci.; 53: 803-10.
• Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med.; 348: 1201-14.
• Eccleston PA, Funa K, Heldin CH. (1993) Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta- receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia. Dev Biol.; 155: 459-70.
• Erlandsson A, Enarsson M, Forsberg-Nilsson K. (2001) Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. JNeurosci.; 21: 3483-91.
• Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B. (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF- BB. Proc Natl Acad Sci U S A.; 90: 393-7.
• Fukuoka T, Kitami Y, Okura T, Hiwada K. (1999) Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells. J Biol Chem.; 274: 25576-82.
• Funa K, Ähgren A. (1997) Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA. Cell Growth Differ.; 8: 861-9.
• Gilbertson DG, Duff ME, West JW, Kelly JD, Sheppard PO, Hofstrand PD, Gao Z, Shoemaker K, Bukowski TR, Moore M, Feldhaus AL, Humes JM, Palmer TE, Hart CE. (2001) Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem.; 276: 27406-14.
• Gravestein LA, Borst J. (1998) Tumor necrosis factor receptor family members in the immune system. Semin Immunol.; 10: 423-34.
• Hackzell A, Uramoto H, Izumi H, Kohno K, Funa K. (2002) p73 independent of c-Myc represses transcription of platelet- derived growth factor beta-receptor through interaction with NF-Y. J Biol Chem.; 277: 39769-76.
• Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science.; 299: 708-10.
• Heldin CH, Ostman A, Ronnstrand L. (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta.; 1378: F79-113.
• Heldin CH, Westermark B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev.; 79: 1283-316.
• Heldin CH, Eriksson U, Ostman A. (2002) New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys; 398: 284-90.
• Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development.; 126: 3047-55.
• Henriksen R, Funa K, Wilander E, Backstrom T, Ridderheim M, Oberg K. (1993) Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res.; 53: 4550-4.
• Hermanson M, Nister M, Betsholtz C, Heldin CH, Westermark B, Funa K. (1988) Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA.; 85: 7748-52.
• Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M. (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res.; 52: 3213-9.
• Hu Y, Bock G, Wick G, Xu Q. (1998) Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress. FASEB J.; 12: 1135-42.
• Hu Y, Szente B, Kiely JM, Gimbrone MA Jr. (2001) Molecular events in transmembrane signaling via E-selectin. SHP2 association, adaptor protein complex formation and ERK1/2 activation. J Biol Chem.; 276: 48549-53.
• Hui AB, Lo KW, Yin XL, Poon WS, Ng HK. (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest.; 81: 717-23.
• Irwin MS, Kaelin WG. (2001) p53 family update: p73 and p63 develop their own identities. Cell Growth Differ.; 12: 337- 49.
• Ishisaki A, Murayama T, Ballagi AE, Funa K. (1997) Nuclear factor Y controls the basal transcription activity of the mouse platelet-derived-growth-factor beta-receptor gene. Eur J Biochem.; 246: 142-6.
• Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K. (2001) Mechanism for the transcriptional repression by c- Myc on PDGF beta-receptor. J Cell Sci.; 114: 1533-44.
• Kapeller R, Chakrabarti R, Cantley L, Fay F, Corvera S. (1993) Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3' kinase complexes: potential interactions with the microtubule cytoskeleton. Mol Cell Biol.; 13: 6052-63.
• Kawagishi J, Kumabe T, Yoshimoto T, Yamamoto T. (1995) Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA. Genomics.; 30: 224-32.
• Kim IS, Sinha S, de Crombrugghe B, Maity SN. (1996) Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Mol Cell Biol.; 16: 4003-13.
• Kitami Y, Fukuoka T, Okura T, Takata Y, Maguchi M, Igase M, Kohara K, Hiwada K. (1998) Molecular structure and function of rat platelet-derived growth factor beta-receptor gene promoter. J Hypertens.; 16: 437-45.
• Langerak AW, van der Linden-van Beurden CA, Versnel MA. (1996) Regulation of differential expression of platelet- derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines. Biochim Biophys Acta.; 1305: 63-70.
• Li H, Fredriksson L, Li X, Eriksson U. (2003) PDGF-D is a potent transforming and angiogenic growth factor. Oncogene.; 22: 1501-10.
• Lindahl P, Johansson BR, Leveen P, Betsholtz C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science.; 277: 242-5.
• Lindroos PM, Coin PG, Badgett A, Morgan DL, Bonner JC. (1997) Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL- 1beta-dependent mechanism. Am JRespir Cell Mol Biol.; 16: 283-92.
• MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer RJ, Cogen P, Stephan DA. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet.; 29: 143-52.
• Mantovani R. (1998) A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res.; 26: 1135-43.
• Markova B, Herrlich P, Ronnstrand L, Böhmer FD. (2003) Identification of protein tyrosine phosphatases associating with the PDGF receptor. Biochemistry.; 42: 2691-9.
• Miyake S, Mullane-Robinson KP, Lill NL, Douillard P, Band H. (1999) Cbl-mediated negative regulation of platelet- derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain. J Biol Chem.; 274: 16619-28.
• Molander C, Kallin A, Izumi H, Ronnstrand L, Funa K. (2000) TNF-alpha suppresses the PDGF beta-receptor kinase. Exp Cell Res. ; 258: 65-71.
• Molander C, Hackzell A, Ohta M, Izumi H, Funa K. (2001) Sp1 is a key regulator of the PDGF beta-receptor transcription. Mol Biol Rep.; 28: 223-33 .
• Oster SK, Marhin WW, Asker C, Facchini LM, Dion PA, Funa K, Post M, Sedivy JM, Penn LZ. (2000) Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol Cell Biol.; 20: 6768-78.
• Ostman A, Heldin CH. (2001) Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res.; 80: 1-38.
• Paulsson Y, Karlsson C, Heldin CH, Westermark B. (1993) Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alha-receptors. J Cell Physiol.; 157: 97-103.
• Pietras K, Ostman A, Sjoquist M, Buchdunger E, Reed RK, Heldin CH, Rubin K. (2001) Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res.; 61: 2929-34.
• Pietras K, Rubin K, Sjoblom T, Buchdunger E, Sjoquist M, Heldin CH, Ostman A. (2002) Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res.; 62: 5476-84.
• Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A. (2003) PDGF receptors as cancer drug targets. Cancer Cell.; 3: 439-43.
• Pinzani M, Gentilini A, Caligiuri A, De Franco R, Pellegrini G, Milani S, Marra F, Gentilini P. (1995) Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology.; 21: 232-9.
• Raff MC. (1989) Glial cell diversification in the rat optic nerve. Science.; 243: 1450-5.
• Rakhit S, Pyne S, Pyne NJ. (2000) The platelet-derived growth factor receptor stimulation of p42/p44 mitogen-activated protein kinase in airway smooth muscle involves a G-protein-mediated tyrosine phosphorylation of Gab1. Mol Pharmacol.; 58: 413-20.
• Reuterdahl C, Tingstrom A, Terracio L, Funa K, Heldin CH, Rubin K. (1991) Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium. Lab Invest.; 64: 321-9.
• Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B. (1993) Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest.; 91: 2065-75.
• Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin CH. (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors.; 7: 261-6.
• Roche S, McGlade J, Jones M, Gish GD, Pawson T, Courtneidge SA. (1996) Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. EMBO J.; 15: 4940-8.
• Ronnstrand L, Arvidsson AK, Kallin A, Rorsman C, Hellman U, Engstrom U, Wernstedt C, Heldin CH. (1999) SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis. Oncogene.; 18: 3696-702.
• Sasahara M, Fries JWU, Raines EW, Gown AM, Westrum LE, Frosch MP, Bonthron DT, Ross R, Collins T. (1991) PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell.; 64: 217-27.
• Shinbrot E, Liao X, Williams LT. (1997) Isolation and characterization of the platelet-derived growth factor beta receptor promoter. DevDyn.; 208: 211-9.
• Sirvent N, Maire G, Pedeutour F. (2003) Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer.; 37: 1-19.
• Sjoblom T, Boureux A, Ronnstrand L, Heldin CH, Ghysdael J, Ostman A. (1999) Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein. Oncogene.; 18: 7055-62.
• Skobe M, Fusenig NE. (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci US A.; 95: 1050-5.
• Smits A, Hermansson M, Nister M, Karnushina I, Heldin CH, Westermark B, Funa K. (1989) Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors.; 2: 1-8.
• Smits A, Funa K, Vassbotn FS, Beausang-Linder M, af Ekenstam F, Heldin CH, Westermark B, Nister M. (1992) Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am J Pathol. ; 140: 639-48.
• Smits A, Ballagi AE, Funa K. (1993) PDGF-BB exerts trophic activity on cultured GABA interneurons from the newborn rat cerebellum. Eur J Neurosci.; 5: 986-94.
• Soriano P. (1997) The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development.; 124: 2691-700.
• Sorkin A, Eriksson A, Heldin CH, Westermark B, Claesson-Welsh L. (1993) Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization. J Cell Physiol.; 156: 373-82.
• Sundberg C, Branting M, Gerdin B, Rubin K. (1997) Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells. Am J Pathol.; 151: 479-92.
• Tallquist MD, Soriano P. (2003) Cell autonomous requirement for PDGFR alpha in populations of cranial and cardiac neural crest cells. Development.; 130: 507-18.
• Tamura K, Yokote K, Takemoto M, Matsumoto T, Ishisaki A, Funa K, Saito Y, Mori S. (1998) Fibronectin stimulates transcription of the platelet-derived growth factor beta-receptor in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun.; 251: 677-80.
• Terracio L, Ronnstrand L, Tingstrom A, Rubin K, Claesson-Welsh L, Funa K, Heldin CH. (1988) Induction of platelet- derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing. J Cell Biol.; 107: 1947-57.
• Tingstrom A, Reuterdahl C, Lindahl P, Heldin CH, Rubin K. (1992) Expression of platelet-derived growth factor-beta receptors on human fibroblasts. Regulation by recombinant platelet-derived growth factor-BB, IL-1, and tumor necrosis factor-alpha. J Immunol.; 148: 546-54.
• Uehara H, Kim SJ, Karashima T, Shepherd DL, Fan D, Tsan R, Killion JJ, Logothetis C, Mathew P, Fidler IJ. (2003) Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J Natl Cancer Inst.; 95: 458-70.
• Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M, Yasumoto K, Funa K, Kohno K. (2002) p73 interacts with c- Myc to regulate YB-1 expression. J Biol Chem.; 277: 31694-702.
• Vaziri C, Faller DV. (1995) Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts. Mol Cell Biol.; 15: 1244-53 .
• Vaziri C, Faller DV. (1996) Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts. J Biol Chem.; 271: 13642-8.
• Waltenberger J, Akyurek ML, Aurivillius M, Wanders A, Larsson E, Fellstrom B, FunaK. (1996) Ischemia-induced transplant arteriosclerosis in the rat. Induction of peptide growth factor expression. Arterioscler Thromb Vasc Biol.; 16: 1516-23.
• Wang C, Stiles CD. (1994) Platelet-derived growth factor alpha receptor gene expression: isolation and characterization of the promoter and upstream regulatory elements. Proc Natl Acad Sci US A.; 91: 7061-5.
• Wang JL, Nister M, Bongcam-Rudloff E, Ponten J, Westermark B. (1996) Suppression of platelet-derived growth factor alpha- and beta-receptor mRNA levels in human fibroblasts by SV40 T/t antigen. J Cell Physiol.; 166: 12-21.
• Yamamoto M, Toya Y, Jensen RA, Ishikawa Y. (1999) Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp Cell Res. ; 247: 380-8.
• Yeh H-J, Ruit KG, Wang Y-X, Parks WC, Snider WD, Deuel TF. (1991) PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell.; 64: 209-16.
• Zaika A, Irwin M, Sansome C, Moll UM. (2001) Oncogenes induce and activate endogenous p73 protein. J Biol Chem. ; 276: 11310-6.
• Zhang QX, Walker F, Burgess AW, Baldwin GS. (1995) Reduction in platelet-derived growth factor receptor mRNA in v- src- transformed fibroblasts. Biochim Biophys Acta.; 1266: 9-15.
• Zhao J, Roth J, Bode-Lesniewska B, Pfaltz M, Heitz PU, Komminoth P. (2002) Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes Cancer.; 34: 48-57.